J
John C. Burnett
Researcher at University of Rochester
Publications - 27
Citations - 6431
John C. Burnett is an academic researcher from University of Rochester. The author has contributed to research in topics: Natriuretic peptide & Brain natriuretic peptide. The author has an hindex of 15, co-authored 27 publications receiving 6091 citations. Previous affiliations of John C. Burnett include Mayo Clinic.
Papers
More filters
Journal ArticleDOI
Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic.
Margaret M. Redfield,Steven J. Jacobsen,John C. Burnett,Douglas W. Mahoney,Kent R. Bailey,Richard J. Rodeheffer +5 more
TL;DR: In the community, systolic dysfunction is frequently present in individuals without recognized CHF and diastolic dysfunction as rigorously defined by comprehensive Doppler techniques is common, often not accompanied by recognizedCHF, and associated with marked increases in all-cause mortality.
Journal ArticleDOI
Plasma brain natriuretic peptide concentration: impact of age and gender.
Margaret M. Redfield,Richard J. Rodeheffer,Steven J. Jacobsen,Douglas W. Mahoney,Kent R. Bailey,John C. Burnett +5 more
TL;DR: Investigation of the effects of age and gender on plasma brain natriuretic peptide concentration in a population-based study confirmed that discriminatory values for BNP for detection of reduced ejection fraction were higher in women and older persons and were different between the two assays.
Journal ArticleDOI
Burden of systolic and diastolic ventricular dysfunction in the community appreciating the scope of the heart failure epidemic
Margaret M. Redfield,Steven J. Jacobsen,John C. Burnett,Douglas W. Mahoney,Kent R. Bailey,Richard J. Rodeheffer +5 more
TL;DR: In this article, the prevalence of diastolic dysfunction and its relation to systolic dysfunction in the community were determined by a Doppler echocardiographic assessment.
Journal ArticleDOI
Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.
Kazuhiro Yamamoto,John C. Burnett,Michihisa Jougasaki,Rick A. Nishimura,Kent R. Bailey,Yoshihiko Saito,Kazuwa Nakao,Margaret M. Redfield +7 more
TL;DR: An elevated plasma BNP was a more powerful marker ofleft ventricular systolic dysfunction, left ventricular diastolic function and left vent cardiac hypertrophy than C-terminal ANP or N-terminAL ANP-(1-30) in this population of patients with suspected cardiac disease.
Journal ArticleDOI
Amino-Terminal Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide in the General Community Determinants and Detection of Left Ventricular Dysfunction
Lisa C. Costello-Boerrigter,Guido Boerrigter,Margaret M. Redfield,Richard J. Rodeheffer,Lynn H. Urban,Douglas W. Mahoney,Steven J. Jacobsen,Denise M. Heublein,John C. Burnett +8 more
TL;DR: Amino-terminal pro-BNP in normal patients is affected primarily by gender and age, which should be considered when interpreting values, and in the entire population sample NT-proBNP performed at least equivalently to BNP in detecting LV dysfunction and was superior in some subgroups in detectingLV systolic dysfunction.